These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 35226830

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Circ_0003159 upregulates LIFR expression through competitively binding to miR-221-3p/miR-222-3p to block gastric cancer development.
    Zheng L, Yan B, Jin G, Han W, Wang H, Wang Z, Ma Y, Nian Y, Meng X, Jiang Z.
    J Mol Histol; 2022 Apr; 53(2):173-186. PubMed ID: 35034206
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
    Sun GL, Li Z, Wang WZ, Chen Z, Zhang L, Li Q, Wei S, Li BW, Xu JH, Chen L, He ZY, Ying K, Zhang X, Xu H, Zhang DC, Xu ZK.
    J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082
    [Abstract] [Full Text] [Related]

  • 29. MiR-200c-3p aggravates gastric cell carcinoma via KLF6.
    Wang Y, Lu K, Li W, Wang Z, Ding J, Zhu Z, Li Z.
    Genes Genomics; 2021 Nov; 43(11):1307-1316. PubMed ID: 34524611
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. MiR-200a-3p promotes gastric cancer progression by targeting DLC-1.
    Li Z, Wang Y, Liu S, Li W, Wang Z, Jia Z, Zhu Z, Bao Y.
    J Mol Histol; 2022 Feb; 53(1):39-49. PubMed ID: 34751841
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis.
    Pan J, Zang Y.
    Dig Dis Sci; 2022 Jul; 67(7):2936-2947. PubMed ID: 34313922
    [Abstract] [Full Text] [Related]

  • 36. miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer.
    Jiang M, Shi L, Yang C, Ge Y, Lin L, Fan H, He Y, Zhang D, Miao Y, Yang L.
    Cell Death Dis; 2019 Jan 10; 10(1):32. PubMed ID: 30631050
    [Abstract] [Full Text] [Related]

  • 37. Anti-cancer effect of miR-139-3p on laryngeal squamous cell carcinoma by targeting rab5a: In vitro and in vivo studies.
    Ma Y, Gong Z, Wang H, Liang Y, Huang X, Yu G.
    Pathol Res Pract; 2020 Nov 10; 216(11):153194. PubMed ID: 32916448
    [Abstract] [Full Text] [Related]

  • 38. HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization.
    Tang C, Lei X, Xiong L, Hu Z, Tang B.
    Cell Death Dis; 2021 Apr 29; 12(5):422. PubMed ID: 33927188
    [Abstract] [Full Text] [Related]

  • 39. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells.
    Zhang X, Dai X, Zhao X, Wang J, Dou J, Zhuang H, Chen N, Zhao H.
    Bioengineered; 2022 Mar 29; 13(3):7082-7104. PubMed ID: 35282764
    [Abstract] [Full Text] [Related]

  • 40. LINC00152 down-regulated miR-193a-3p to enhance MCL1 expression and promote gastric cancer cells proliferation.
    Huang Y, Luo H, Li F, Yang Y, Ou G, Ye X, Li N.
    Biosci Rep; 2018 Jun 29; 38(3):. PubMed ID: 29339419
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.